| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥92.0B | ¥23.4B | +292.8% |
| Operating Income | ¥44.1B | ¥-0.8B | +5985.3% |
| Profit Before Tax | ¥45.0B | ¥-0.8B | +5722.5% |
| Net Income | ¥29.6B | ¥-0.9B | +3539.5% |
| ROE | 19.8% | -4.9% | - |
FY2026 Q3 cumulative results: Revenue 92.0B yen (YoY +292.8%), Operating Income 44.1B yen (prior period loss of 0.8B yen, +5985.3%), Ordinary Income 45.0B yen, Net Income 29.6B yen (prior period loss of 0.9B yen, +3539.5%). The company achieved a dramatic turnaround from prior year losses to substantial profitability, with operating margin reaching 48.0%. This represents the first period of profitable operations following business restructuring and consolidation of new subsidiaries. Basic EPS improved to 6.38 yen from negative 0.20 yen in the prior period. The transformation reflects significant business portfolio reorganization, including establishment of Consulting segment as independent reporting unit and expansion through strategic investments.
Revenue increased 68.9B yen YoY to 92.0B yen, driven primarily by three newly expanded business segments. Consulting segment generated 35.3B yen in external sales, marking its first period of substantial external revenue following independence from Nail segment. Investment & Advisory segment contributed 15.6B yen, up significantly from 9.5M yen in prior period, reflecting expanded M&A advisory and investment activities. Healthcare segment revenue reached 17.2B yen compared to 8.9M yen previously, indicating successful scaling of pharmaceutical import agency services. Nail segment, the legacy core business, showed modest growth to 23.8B yen from 23.2B yen. The revenue composition shift demonstrates successful diversification from single-segment concentration to multi-business platform model.
Operating profit surged to 44.1B yen from negative 0.8B yen, benefiting from both revenue scale expansion and significant margin improvement. Operating margin reached 48.0%, reflecting the high-margin nature of consulting and advisory services. Other income of 7.2B yen (compared to 21M yen prior period) contributed to profitability, though details were not disclosed as non-recurring factors. Cost of sales increased to 42.3B yen from 14.7B yen, but gross margin improved to 54.0% from 37.2%. Selling, general and administrative expenses rose to 12.2B yen from 9.3B yen, growing at substantially lower rate than revenue, indicating operational leverage benefits.
The gap between operating income (44.1B yen) and net income (29.6B yen) represents 14.5B yen, primarily attributable to income tax expense of 15.4B yen. Finance income contributed 0.96B yen while finance costs remained minimal at 0.12B yen. The effective tax rate of approximately 34.3% on pre-tax profit of 45.0B yen aligns with standard corporate tax rates, with no material extraordinary tax adjustments evident.
This represents a revenue up/profit up pattern with significant margin expansion, driven by business model transformation from primarily B2C nail services to B2B consulting and advisory services commanding higher unit economics.
Consulting segment delivered revenue of 36.5B yen (including 1.2B yen inter-segment) with segment profit of 11.6B yen, representing 31.9% margin. This became the largest segment by revenue in its first period as independent reporting unit, reflecting rapid scaling of Convano Consulting subsidiary's strategy and implementation support services. Investment & Advisory segment achieved revenue of 15.6B yen with segment profit of 21.1B yen, yielding exceptional 135% margin that likely reflects realization of investment gains and advisory fee structures with minimal cost base. Healthcare segment generated revenue of 17.2B yen with segment profit of 11.7B yen (67.9% margin), demonstrating the high-margin pharmaceutical import agency model. Nail segment produced revenue of 23.8B yen with segment profit of 1.2B yen (5.1% margin), representing the lowest profitability among segments due to labor-intensive salon operations and franchise model economics. Corporate unallocated expenses totaled 1.5B yen.
The Investment & Advisory segment emerged as the most profitable contributor despite being second-smallest by revenue, indicating its role as core earnings driver. Healthcare segment combines both scale and high margins, positioning it as balanced growth engine. Consulting segment demonstrates strong operating leverage potential as it scales. Nail segment functions as stable revenue base with room for margin improvement through operational efficiency initiatives.
[Profitability] ROE 19.8% demonstrates strong return on equity in first profitable period, operating margin 48.0% significantly exceeds typical service industry benchmarks, net profit margin 32.2% reflects high earnings quality from advisory and consulting operations. [Cash Quality] Cash and equivalents 34.5B yen increased from 8.1B yen prior year, short-term debt coverage stands at 0.73x against current borrowings of 2.9B yen and bonds payable of 25.0B yen, indicating refinancing requirements ahead. Operating cash flow of 23.7B yen represents 0.80x conversion ratio against net income, warranting monitoring of working capital efficiency. [Investment Efficiency] Asset turnover 0.40 reflects capital-intensive intangible asset base, receivables turnover 112 days indicates extended collection cycles requiring attention. [Financial Health] Equity ratio 65.4% provides strong capital buffer, current ratio calculated at approximately 0.93x (current assets 67.4B yen vs current liabilities 72.4B yen) signals near-term liquidity management priority, debt-to-equity ratio 0.04 for interest-bearing debt remains minimal, though short-term liabilities ratio of 48.1% indicates refinancing risk concentration.
Operating cash flow of 23.7B yen represents 0.80x of net income, with the gap primarily attributable to working capital expansion. Cash flow from operations before working capital changes reached 24.2B yen, closely tracking profit generation. Trade receivables increased 19.9B yen, absorbing significant cash as DSO extended to 112 days amid rapid revenue scaling. Trade payables increased 15.4B yen, partially offsetting receivables growth through supplier credit utilization. Income taxes paid of 0.5B yen remained modest relative to tax expense of 15.4B yen, indicating deferred tax payment timing. Investing cash flow of negative 118.0B yen was dominated by intangible asset acquisitions totaling approximately 141.1B yen on balance sheet, reflecting major strategic investments in intellectual property, customer relationships, or business acquisitions. Capital expenditure of 0.3B yen remained minimal for physical assets. Financing cash flow of 120.8B yen comprised primarily capital raising activities, likely including equity issuance (capital increased from 100M yen to 52.4B yen) and bond issuance (25.0B yen bonds payable), funding the large-scale intangible asset investments. Share repurchases totaled 0.2B yen. Free cash flow of negative 94.3B yen reflects investment phase priorities, with external funding bridging the gap. Cash position increased to 34.5B yen from 8.1B yen, though coverage against short-term obligations of approximately 72.4B yen indicates liquidity management remains critical priority through FY2026.
Ordinary income of 45.0B yen versus operating income of 44.1B yen shows minimal non-operating variance of 0.9B yen, indicating core business operations drive substantially all earnings. Finance income of 0.96B yen likely comprises interest income, dividend income, and foreign exchange gains, while finance costs of 0.12B yen remain negligible relative to total debt levels. Non-operating income represents approximately 1% of revenue, maintaining earnings purity. Other income of 7.2B yen classified above operating income warrants clarification regarding recurring nature, though management has not disclosed specific extraordinary items or impairments for the current period. Operating cash flow of 23.7B yen falls short of net income at 0.80x conversion, indicating accrual-based earnings outpacing cash realization. This gap stems primarily from trade receivables growth of 19.9B yen, suggesting revenue recognition precedes cash collection by approximately 3.7 months. The extended DSO of 112 days versus industry median of 61 days raises questions regarding billing terms, customer credit quality, or revenue recognition policies. Absent material provisions for doubtful accounts or impairment charges in disclosed data, receivables appear carried at face value, introducing collection risk. The significant intangible asset base of 141.1B yen (61.8% of total assets) requires ongoing impairment testing, though no impairment losses were recorded in current period compared to 65M yen in prior period. Overall earnings quality exhibits strong profitability metrics tempered by working capital management concerns and intangible asset recoverability dependencies.
Full-year guidance targets revenue of 149.5B yen, operating income of 59.9B yen, and net income of 39.2B yen. Q3 cumulative progress rates stand at 61.5% for revenue, 73.7% for operating income, and 75.5% for net income against full-year targets. Operating income and net income progress rates exceed the standard 75% benchmark for Q3, suggesting conservative full-year guidance or potential Q4 seasonality factors. Revenue progress at 61.5% trails the 75% standard by 13.5 percentage points, implying substantial Q4 acceleration required to 57.5B yen (versus Q3 cumulative 92.0B yen over 9 months, averaging 30.7B yen per quarter). Management disclosed no forecast revisions during Q3, maintaining prior guidance despite strong interim performance. Dividend forecast remains at 1.00 yen per share annually, with dividend revision noted during the quarter though specific changes were not quantified in available data. Forecast assumptions reference standard disclaimers regarding information availability and premise reasonableness without specific operating assumptions disclosed. No order backlog data is available to assess forward revenue visibility for service-based segments.
Annual dividend forecast stands at 1.00 yen per share for FY2026, representing the company's first anticipated dividend payment following return to profitability. Based on forecasted EPS of 7.70 yen, the implied payout ratio calculates to 13.0%, indicating highly conservative dividend policy prioritizing earnings retention for growth investments. No dividends were paid in prior periods given loss-making status. Share repurchases during Q3 cumulative period totaled 0.2B yen, representing minimal capital return activity. Total return ratio combining dividends (assuming full-year payout on current shares outstanding) and buybacks would approximate 13-15% of forecasted net income, leaving substantial retained earnings for business reinvestment. The modest shareholder return policy aligns with growth-stage company profile undertaking major strategic investments, though free cash flow generation of negative 94.3B yen indicates current returns are funded through balance sheet cash rather than operational cash generation.
Working capital management risk: Trade receivables of 28.2B yen with DSO of 112 days (versus industry median 61 days) creates collection risk and cash conversion pressure. Further revenue scaling without DSO improvement would absorb increasing cash, potentially straining liquidity despite strong profitability. Customer concentration or payment term structures in consulting and advisory segments may contribute to extended cycles.
Intangible asset recoverability risk: Intangible assets of 141.1B yen representing 61.8% of total assets creates significant impairment vulnerability. The 141.1B yen balance increased from 5.2B yen prior year, primarily through Q3 acquisitions. Future impairment testing depends on sustained revenue and profit generation from acquired customer relationships, intellectual property, or business operations. Failure to achieve projected synergies or market conditions deterioration could trigger material write-downs affecting equity.
Refinancing and liquidity risk: Short-term liabilities ratio of 48.1% with current ratio near 0.93x indicates near-term funding pressure. Bonds payable of 25.0B yen and borrowings of 2.9B yen require refinancing capacity, while operating cash flow of 23.7B yen provides limited debt service coverage if investment activities continue at current pace. Dependence on external financing to fund negative free cash flow of 94.3B yen makes the company vulnerable to capital market conditions or lender sentiment changes.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE 19.8% substantially exceeds IT & Telecom industry median of 8.3% (2025-Q3, IQR: 3.6%-13.1%), positioning Convano in top quartile for equity returns. Operating margin 48.0% far surpasses industry median of 8.2% (IQR: 3.6%-18.0%), reflecting the company's high-margin consulting and advisory business mix versus broader technology sector including hardware and telecommunications infrastructure operators. Net profit margin 32.2% dramatically exceeds industry median of 6.0% (IQR: 2.2%-12.7%), ranking among the highest-margin companies in the sector.
Financial Health: Equity ratio 65.4% exceeds industry median of 59.2% (IQR: 42.5%-72.7%), indicating above-median capital strength. However, current ratio near 0.93x falls well below industry median of 2.15x (IQR: 1.57x-3.62x), highlighting liquidity positioning in bottom quartile despite strong equity base. This divergence reflects recent capital deployment into long-term intangible assets while maintaining elevated short-term liabilities.
Efficiency: Asset turnover 0.40 falls below industry median of 0.67 (IQR: 0.49-0.93), reflecting intangible asset-heavy balance sheet structure. Receivables turnover at 112 days substantially exceeds industry median of 61 days (IQR: 46-83 days), indicating collections management requires improvement to align with sector norms. Operating working capital cycle metrics warrant monitoring relative to professional services peers.
Growth: Revenue growth of 292.8% YoY vastly exceeds industry median of 10.4% (IQR: -1.2%-19.6%), though comparison is distorted by prior period's pre-restructuring baseline. Rule of 40 metric (revenue growth plus operating margin) reaches approximately 341%, exceptional by any standard and reflecting transformation year dynamics rather than sustainable trajectory. Normalized growth assessment will require additional periods post-restructuring.
※ Industry: IT & Telecom (104 companies for most metrics), Comparison: 2025-Q3 period data, Source: Proprietary analysis
Business model transformation achieved: The company successfully transitioned from single-segment nail salon operator to diversified professional services platform spanning consulting, investment advisory, healthcare, and nail services. Q3 results demonstrate economic viability of the new model with 48% operating margins and positive operating leverage, though sustainability depends on continued revenue scaling in high-margin segments and successful integration of acquired intangible assets. The shift from B2C to B2B-dominant revenue mix fundamentally alters the business risk-return profile.
Investment phase cash dynamics: Negative free cash flow of 94.3B yen reflects intentional investment positioning, with intangible asset acquisitions of approximately 141B yen funded through 120.8B yen financing activities including equity issuance (capital increased 52.3B yen) and bond placement (25.0B yen). The company is deploying growth capital rather than harvesting cash, appropriate for expansion stage but creating near-term liquidity management requirements. Operating cash generation of 23.7B yen (0.80x net income conversion) provides modest self-funding capability, requiring external capital access to sustain current investment pace.
Working capital efficiency represents key operational challenge: DSO extension to 112 days (versus 61-day industry median) absorbs 19.9B yen cash in Q3, offsetting 80% of operating cash generation. Revenue scaling without collections improvement would perpetuate cash consumption, limiting financial flexibility. Management priority on DSO reduction to industry-standard levels could unlock substantial cash flow improvement, potentially 10-15B yen based on current revenue run-rate. Payables leverage increased 15.4B yen, demonstrating some working capital optimization, but receivables growth outpaces payables by 1.3x ratio.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.